NAMS
NewAmsterdam Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NAMS Filings
Filing Date
Form Description
Form Type
2025-12-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-07 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-05
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-05 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-11-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-09-30
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-09-30 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
